SelectQuote, Inc. (NYSE:SLQT) reported its Q3 earnings results last week, which came in well above the Street estimates driven by improved operating efficiency from management’s strategic redesign.

Revenue came in at $299.4 million, beating the Street estimate of $260.7 million, driven by better-than-expected volume with approved MA policies of 165,000. Improved close rates from longer-tenured agents using higher quality, targeted leads led to a 17% improvement in marketing expense per approved policy.

The company continues to gain solid adoption with SelectRx, with membership growing 14.5% sequentially to around 45,000.